Tenon Medical Closes $4.2 Million Public Offering

The offering includes 11,052,631 shares of common stock—or pre-funded warrants—paired with warrants to purchase up to 13,263,159 additional shares. Each unit is priced at $0.38. Should Tenon Medical execute a reverse stock split, the number of shares underlying these warrants will climb to 16,578,949.

Management intends to direct the proceeds toward the partial repayment of outstanding convertible notes and the aggressive expansion of its commercial footprint. Plans include hiring additional direct sales representatives, scaling the external distribution network, and funding clinical research to bolster reimbursement efforts. Furthermore, the company will allocate funds to inventory growth and future product development. Legal counsel for the offering was provided by Sichenzia Ross Ference Carmel LLP for the company and Sheppard, Mullin, Richter & Hampton LLP for WallachBeth Capital.